Pharma & Speciality Chemicals
The pharmaceutical industry allows people to prolong their lives and cure, or mitigate, conditions which for previous generations would have had severe consequences. Speciality chemicals uses the high quality ingredients from Fine Chemical producers to create functionalised molecules with properties which consumers value.
Pharma & Speciality Chemicals
Industry Challenges
Generic drugs threaten the profitability of Pharma blockbusters which require years and millions of dollars to develop and commercialise. The technological growth in devices and personal data availability offers opportunities for patients and medical practitioners, but could threaten traditional treatment methods. Speciality Chemical producers have to obtain feedstocks which are in demand across different industries, and meet changing consumer needs. Agrochemicals aim to support the need for resilient and high yield crop production, while flavours and fragrances are sold into an increasingly diverse marketplace.
Pharma & Speciality Chemicals
How We Can Help
ILS helps energy companies to discover how to meet ambitious environmental requirements in a cost effective way. Our parallel reactors reduce the time required to determine the catalyst and process conditions which will meet the changing market needs, and our user friendly software avoids this becoming a headache for laboratory researchers. Running catalyst robustness studies in ILS systems determines how to reduce the downtime for catalyst changeovers. The ILS contract research service helps energy producers with urgent needs access our state of the art research tools.
Case Studies
ILS has helped Pharma and Speciality Chemical companies accelerate research projects through advanced hardware.
Syngenta
Syngenta wanted to increase the reaction throughput by, generate high quality data and avoid cross contamination between reactors. The reactor system ILS developed allowed them to quadruple their throughput with a unit which is straight forward to operate.
Bayer
Bayer approached ILS to request a cost effective unit for hydrogenation studies. It needed to be able to operate around the clock and produce good quality data.
DSM
DSM were interested in a parallel reactor system that was simple to use and could reach high temperatures. They needed to run research projects rapidly and wanted a collaborative company with good engineering abilities.
Discover how to save time when commissioning units
Hear ILS CEO Anton Nagy describe time-saving and practical tips in a series of short videos. You'll learn some of the methods which help ILS manage risk and avoid delays when they deliver highly sophisticated reactor systems.
